INFU

$12.80-7.51%visit website

InfuSystem Holdings, Inc

Market Cap

$255M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.38

60mo monthly vs SPY

P/E (TTM)

32.0

TTM to Jun 2026 · diluted EPS

P/S (TTM)

1.8

TTM to Jun 2026 · revenue

P/B

4.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

10.4

TTM to Jun 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	36,488	36,230	33,684	36,933	143,335
Cost of revenue	15,668	15,795	14,002	15,520	60,985
Gross profit	20,820	20,435	19,682	21,413	82,350
Total operating expenses	17,009	16,721	18,092	17,261	69,083
Operating income	3,811	3,714	1,590	4,152	13,267
Interest expense	330	260	255	255	1,100
Pretax income	3,427	3,497	1,417	3,871	12,212
Income tax	1,168	1,461	400	640	3,669
Net income	2,259	2,036	1,017	3,231	8,543
EPS (basic) ($)	0.11		0.05	0.16	0.42
EPS (diluted) ($)	0.11		0.05	0.15	0.40
Weighted avg. shares (basic)	20,414		20,211	20,071
Weighted avg. shares (diluted)	20,947		20,894	20,920

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 4, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

20 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 8:10 AM ET	7.01Reg FD disclosure	Document SEC ↗
Oct 27, 2026 accepted 6:30 AM ET	7.01Reg FD disclosure	Document SEC ↗
Sep 17, 2026 accepted 4:30 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 4, 2026 accepted 6:46 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 4, 2026 accepted 6:31 AM ET	2.02Earnings release	Document SEC ↗
Jul 28, 2026 accepted 7:40 AM ET	7.01Reg FD disclosure	Document SEC ↗
May 18, 2026 accepted 4:30 PM ET	7.01Reg FD disclosure	Document SEC ↗
May 14, 2026 accepted 9:04 AM ET	5.02Officer / director change	Document SEC ↗
May 12, 2026 accepted 5:21 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 7, 2026 accepted 6:41 AM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

31%

W/W -20.6pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-11	2026-05-12	Lachance Carrie	Director & President and CEO	Purchase	1,000	$8.46	$8K	238.1K	View
2026-05-08	2026-05-12	Steele Barry G	Executive VP and CFO	Purchase	7,000	$8.71	$61K	96.6K	View
2026-05-08	2026-05-12	Lachance Carrie	Director & President and CEO	Purchase	2,000	$8.83	$18K	237.1K	View
2026-05-08	2026-05-12	GENDRON PAUL ANDREW	Director	Purchase	5,000	$8.88	$44K	70.0K	View
2026-03-02	2026-03-02	Steele Barry G	Executive VP and CFO	Purchase	2,064	$9.16	$19K	88.0K	View